Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

FENOFIBRATE (MICRONIZED)

FENOFIBRATE

Standard Dose
43MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview FENOFIBRATE (MICRONIZED) is listed in Drugs@FDA under application 202579 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FENOFIBRATE Form and strength CAPSULE;ORAL - 43MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2022-01-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview FENOFIBRATE (MICRONIZED) is listed in Drugs@FDA under application 202579 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FENOFIBRATE Form and strength CAPSULE;ORAL - 43MG Sponsor PHARMOBEDIENT Submission history Latest submission status date: 2022-01-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
FENOFIBRATE (MICRONIZED) (FENOFIBRATE) | Drug Monograph | MedicHelpline